 Ligand Pharmaceuticals, Inc. NASDAQ:LGND Q2 2022 Earnings Conference Call August 8, 2022 4:30 PM ET Company Participants Simon Latimer - Head, IR John Higgins - CEO Executive Director Matthew Korenberg - EVP, Finance CFO Matthew Foehr - President COO Conference Call Participants Peter Lukas - CJS Securities Matthew Hewitt - Craig-Hallum Operator Welcome to the Ligand Pharmaceuticals Second Quarter Earnings Conference Call. My name is Vanessa, and I will be your operator for todays call. 